Management Team.

The minds behind SignalPath.

SignalPath is made up of distinguished leaders in technology and healthcare. Our team is our foundation and most valuable asset.

Our Management Team

  • brad

    Bradford Hirsch, MD

    Chief Executive Officer &
  • ira

    Ira Grossman

    Chief Operating Officer &
  • alan

    Alan Cox

    Chief Technology Officer
  • gaskill

    Noelle Gaskill

    Vice President of
    Research Operations
  • lori

    Lori McKitrick

    Vice President of
    Client Engagement


Our advisors ensure that SignalPath stays true to its vision and purpose, improving the conduct of research for all stakeholders. They are strong leaders spanning academics, technology and care delivery.


Gabriel Goncalves

Software Entrepreneur & Member, SignalPath Board of Directors

Gab is a software entrepreneur and investor with a proven track record of building successful technology companies. PeopleAnswers, his most recent startup, was acquired by Infor after 40 consecutive quarters of growth. Gab created this predictive talent analytics platform, helping enterprise customers across the globe reduce employee turnover and improve performance.


Robert Harrington, MD

Chair of Medicine, Stanford University & Member, SignalPath Board of Directors

Bob is an interventional cardiologist and leads the Department of Medicine at Stanford University. He has hundreds of publications to his name and is one of the preeminent clinical researchers in the country.


Amy Abernethy, MD, PhD

Chief Medical Officer, Flatiron Health

Amy is an oncologist and palliative medicine physician who is an internationally recognized expert in clinical research, clinical informatics and patient-centered care. In addition to time in academics, she has built successful health technology startups, most recently in her role at Flatiron Health.


Eric Peterson, MD

Executive Director, Duke Clinical Research Institute

Eric is the Fred Cobb Distinguished Professor of Medicine at Duke University and the Executive Director of the Duke Clinical Research Institute (DCRI). The DCRI has flourished under his leadership as the largest academic clinical research organization in the world. Since its inception, the DCRI has completed over 1,000 trials, enrolled over 1.2 million patients, and conducted studies at more then 37,000 sites.